Skip to content
MAIAMAIA Biotechnology, Inc.

Earnings

When MAIA Biotechnology, Inc. reports, what it reported each quarter, and how the stock took the results.

23 quarters. Mar 31, 2021 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

10-K due Mar 18 – 26

No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 4 filings.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 18 – 26

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Revenue, change from a year earlier: Q4 2022 n/m, Q3 2022 n/m
Net income
-$3.63M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q4 2023—

Latest results

  1. Q3 2026Nov 9, 2026, after the close1.4%by the close of Nov 10
    Revenue
    —
    —
    Net income
    -$7.18M
    N/M
    EPS
    -$0.12
    N/M
  2. Q2 2026Aug 10, 2026, before the open2.1%by the close of Aug 10
    Revenue
    —
    —
    Net income
    -$7.94M
    N/M
    EPS
    -$0.13
    N/M
  3. Q1 2026May 11, 2026, before the open0.8%by the close of May 11
    Revenue
    —
    —
    Net income
    -$6.37M
    N/M
    EPS
    -$0.14
    N/M
  4. Q4 2025Mar 23, 2026, before the open+2.1%by the close of Mar 23
    Revenue
    —
    —
    Net income
    -$3.63M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026—Nov 9, 202640 d10-Q——-$0.121.4%
Q2 2026Jun 30, 2026—Aug 10, 202641 d10-Q——-$0.132.1%
Q1 2026Mar 31, 2026—May 11, 202641 d10-Q——-$0.140.8%
FY 2025
Q4 2025derivedDec 31, 2025—Mar 23, 202682 d10-K———+2.1%
Q3 2025Sep 30, 2025—Nov 7, 202538 d10-Q——-$0.27+0.9%
Q2 2025Jun 30, 2025—Aug 11, 202542 d10-Q——-$0.182.6%
Q1 2025Mar 31, 2025—May 9, 202539 d10-Q——-$0.165.0%
FY 2024
Q4 2024derivedDec 31, 2024—Mar 21, 202580 d10-K———4.6%
Q3 2024Sep 30, 2024—Nov 12, 202443 d10-Q——-$0.119.2%
Q2 2024Jun 30, 2024—Aug 9, 202440 d10-Q——-$0.40+1.5%
Q1 2024Mar 31, 2024—May 14, 202444 d10-Q——-$0.46+1.1%
Earlier years, FY 2021 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 9, 2026050757
10-QAug 10, 2026036764
10-QMay 11, 2026022154
10-KMar 23, 2026012088
10-QNov 7, 2025021272
10-QAug 11, 2025022899
10-QMay 9, 2025068005
10-KMar 21, 2025043190
10-QNov 12, 2024125474
10-QAug 9, 2024094747

Provenance

ProvenanceData status and checks

MAIA Biotechnology, Inc. · CIK 1878313 · Engraved from SEC EDGAR